iSpecimen (ISPC) Competitors

iSpecimen (NASDAQ:ISPC) and Greenpro Capital (NASDAQ:GRNQ) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, earnings, institutional ownership, analyst recommendations, valuation and profitability.

Do institutionals & insiders hold more shares of ISPC or GRNQ?

13.6% of iSpecimen shares are owned by institutional investors. Comparatively, 0.9% of Greenpro Capital shares are owned by institutional investors. 12.2% of iSpecimen shares are owned by company insiders. Comparatively, 45.4% of Greenpro Capital shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Does the media prefer ISPC or GRNQ?

In the previous week, iSpecimen had 2 more articles in the media than Greenpro Capital. MarketBeat recorded 6 mentions for iSpecimen and 4 mentions for Greenpro Capital. iSpecimen's average media sentiment score of 0.59 beat Greenpro Capital's score of 0.39 indicating that iSpecimen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iSpecimen	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Greenpro Capital	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has preferable earnings and valuation, ISPC or GRNQ?

Greenpro Capital has lower revenue, but higher earnings than iSpecimen. Greenpro Capital is trading at a lower price-to-earnings ratio than iSpecimen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iSpecimen	$9.29M	0.31	-$12.50M	-$12.89	-0.09
Greenpro Capital	$3.50M	3.62	-$710K	-$0.13	-11.77

Which has more volatility and risk, ISPC or GRNQ?

iSpecimen has a beta of 1.65, suggesting that its stock price is 65% more volatile than the S&P 500. Comparatively, Greenpro Capital has a beta of 1.42, suggesting that its stock price is 42% more volatile than the S&P 500.

Is ISPC or GRNQ more profitable?

Greenpro Capital has a net margin of -33.68% compared to iSpecimen's net margin of -139.63%. Greenpro Capital's return on equity of -20.85% beat iSpecimen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iSpecimen	-139.63%	-285.20%	-114.37%
Greenpro Capital	-33.68%	-20.85%	-15.55%

Summary

Greenpro Capital beats iSpecimen on 7 of the 13 factors compared between the two stocks.